Alloy Ventures, Inc. sold $3.45M worth of shares in Pacific Biosciences of California, Inc. in February 2020

Mar 08, 2020
Insider Transactions
Background Information
Alloy Ventures focuses on seed and early-stage venture capital investments in the life sciences, information technology and clean technology sectors. The firm may also consider later-stage investments. Within the life sciences sector, Alloy Ventures focuses on medical devices, laboratory instrumentation and diagnostics. Their information technology investments focus on software, systems, mobile and semiconductors. The firm targets clean technology investments in the solar and biotechnology fields.The firm syndicates all of their investments with other venture funds but they do not depend on others for deal flow. Alloy Ventures is usually the first institutional investor in their portfolio companies. Initial investments range from $1 million to $5 million with additional capital reserved for subsequent financing rounds. Alloy Ventures may also consider much smaller investments.
Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.